As many physicians now restrict the access they offer to sales reps from pharma brands, programmatic advertising is emerging as a potential means of engaging this harder-to-reach, but still invaluable, audience.

While programmatic ads – which offer the ability to digitally target doctors in a way that’s accurate, compliant, and relatively inexpensive – is comparatively new to the pharma space, it is becoming hard to ignore for many brands.

Among the reasons for this shift are the high costs and lack of targeting offered by direct-to-consumer (DTC) television ads, according to Chris Neuner, SVP/general manager of PulsePoint Digital Health, a customized programmatic platform for healthcare.

123538f01

Chris Neuner, SVP/general manager, PulsePoint Digital Health